Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
Birgit Girshick
CEOBirgit Girshick
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
16.48B
Market cap16.48B
Price-Earnings ratio
-70.00
Price-Earnings ratio-70.00
Dividend yield
—
Dividend yield—
Average volume
1.17M
Average volume1.17M
High today
$347.20
High today$347.20
Low today
$332.17
Low today$332.17
Open price
$334.88
Open price$334.88
Volume
804.74K
Volume804.74K
52 Week high
$351.21
52 Week high$351.21
52 Week low
$146.20
52 Week low$146.20

Stock Snapshot

With a market cap of 16.48B, Charles River(CRL) trades at $345.37. The stock has a price-to-earnings ratio of -70.00.

During the trading session on 2026-10-23, Charles River(CRL) shares reached a daily high of $347.20 and a low of $332.17. At a current price of $345.37, the stock is +4.0% higher than the low and still -0.5% under the high.

Trading volume for Charles River(CRL) stock has reached 804.74K, versus its average volume of 1.17M.

Over the past 52 weeks, Charles River(CRL) stock has traded between a high of $351.21 and a low of $146.20.

Over the past 52 weeks, Charles River(CRL) stock has traded between a high of $351.21 and a low of $146.20.

CRL News

MarketWatch 1d
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch

...

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TipRanks 1d
Labcorp, Charles River and FDA to collaborate to evaluate drug abuse potential

Labcorp (LH) announced a collaboration with the FDA and Charles River Laboratories (CRL) to advance the science used to evaluate a medicine’s abuse potential, o...

Simply Wall St 6d
Charles River Laboratories International Earnings Beat Puts Fair Value Back In Focus

Charles River Laboratories International (CRL) drew fresh attention after quarterly revenue of US$1.00b came in 2.5% above analyst expectations, with organic sa...

Charles River Laboratories International Earnings Beat Puts Fair Value Back In Focus

Analyst ratings

70%

of 20 ratings
Buy
70%
Hold
20%
Sell
10%

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.